|
|
|
Volumn 24, Issue 1 SUPPL. 4, 1997, Pages
|
|
Treatment of malignant melanoma with interleukin-2
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RECOMBINANT INTERLEUKIN 2;
INTERLEUKIN 2;
RECOMBINANT PROTEIN;
ADOPTIVE IMMUNOTHERAPY;
CANCER IMMUNOTHERAPY;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
DOSE RESPONSE;
HUMAN;
IMMUNOMODULATION;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY DISEASE;
LYMPHOCYTOSIS;
LYMPHOKINE ACTIVATED KILLER CELL;
MAJOR CLINICAL STUDY;
MELANOMA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TREATMENT OUTCOME;
TUMOR ASSOCIATED LEUKOCYTE;
METASTASIS;
SKIN TUMOR;
T LYMPHOCYTE;
TRANSPLANTATION;
CLINICAL TRIALS;
HUMANS;
INTERLEUKIN-2;
KILLER CELLS, LYMPHOKINE-ACTIVATED;
MELANOMA;
NEOPLASM METASTASIS;
RECOMBINANT PROTEINS;
SKIN NEOPLASMS;
T-LYMPHOCYTES;
TREATMENT OUTCOME;
|
|
EID: 0030892250
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (22)
|
|
References (64)
|
